
    
      A prospective comparative randomized clinical trial was designed to evaluate the healing and
      bony regeneration in patients who received 1 of 3 different retrograde filling materials
      (EndoSequence®, ProRoot® MTA, or Biodentine®) following microsurgical apicoectomies for the
      treatment of periapical lesions of endodontic origin.
    
  